CASTLE PARTNERSHIP
40 FISHERGATE, NORWICH
Stroke 12
The % of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record that an anti-platelet agent (aspirin, clopidogrel, dipyridamole or a combination), or an anti-coagulant is being taken (unless a contraindication or side-effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| STROKE 9 | 2005 | 256 | 287 | 89.2% | |
| STROKE 9 | 2006 | 265 | 293 | 90.4% | |
| Stroke 12 | 2007 | 282 | 300 | 94.0% | |
| Stroke 12 | 2008 | 287 | 306 | 93.8% | |
| Stroke 12 | 2009 | 293 | 312 | 93.9% | |
| Stroke 12 | 2010 | 282 | 306 | 92.2% | |
| STROKE 12 | 2011 | 270 | 295 | 91.5% | |
| STROKE 12 | 2012 | 279 | 304 | 91.8% | |
| STROKE 12 | 2013 | 247 | 261 | 94.6% | |
| STIA007 | 2014 | 241 | 250 | 96.4% | |
| STIA007 | 2015 | 243 | 247 | 98.4% | |
| STIA007 | 2016 | 257 | 260 | 98.8% | |
| STIA007 | 2017 | 250 | 251 | 99.6% | |
| STIA007 | 2018 | 264 | 272 | 97.1% | |
| STIA007 | 2019 | 265 | 272 | 97.4% | |
| STIA007 | 2020 | 273 | 281 | 97.2% | |
| STIA007 | 2021 | 245 | 280 | 87.5% | |
| STIA007 | 2022 | 266 | 271 | 98.2% | |
| STIA007 | 2023 | 279 | 285 | 97.9% |
